跳至主要内容
临床试验/CTRI/2024/08/072215
CTRI/2024/08/072215尚未招募2 期

A prospective clinical study to determine the therapeutic dose of Centchroman in the manangement of cyclical mastalgia - NI

ttar Pradesh University of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All women with mastalgia with VAS score =3 lasting for more than 5-7 days per cycle were included after signing a consent form.

排除标准

  • Patients with polycystic ovarian diseases and uterine cervical hyperplasia.
  • First six months of Lactation and pregnancy
  • Patients who were not giving consent.
  • Past history of breast carcinoma or family history of breast carcinoma
  • Patient who were planning for pregnancy .
  • Women suspected or diagnosed of malignancy
  • Recent history of jaundice or hepatic impairment.
  • Severe allergic states.
  • History of thrombosis.

研究者

发起方
ttar Pradesh University of Medical Sciences

相似试验